Get started
Author

Jenny M. Goble

Observed institution: Mayo Clinic
OpenAlex ID: A5012102991
Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2006 · Cory Allen, Sompong Vongpunsawad, et al. · Cancer Research · 107
Supplementary Figure 1 from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023 · Cory Allen, Sompong Vongpunsawad, et al.
PDF
Supplementary Figure Legend from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023 · Cory Allen, Sompong Vongpunsawad, et al.
Supplementary Figure 1 from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023 · Cory Allen, Sompong Vongpunsawad, et al.
Data from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023 · Cory Allen, Sompong Vongpunsawad, et al.
Data from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023 · Cory Allen, Sompong Vongpunsawad, et al.
Supplementary Figure Legend from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
2023 · Cory Allen, Sompong Vongpunsawad, et al.
PDF
Works count: 7
Citation count: 107
H-index: 1
I10-index: 1
Year
Topic
Type